Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on L 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel alkylammonium acetate method for AcHMF. High yield, base-free process. Reliable supply chain for pharmaceutical intermediates and biomass-derived platform compounds.
Patent CN111187148A enables simultaneous production with 97% selectivity. Offers cost reduction in pharma intermediates manufacturing and enhanced supply chain reliability for global buyers.
Patent CN108239091B details a robust chemical resolution for NLG919 precursors. This method offers high optical purity, recoverable reagents, and scalable manufacturing for pharmaceutical supply chains.
Patent CN108239091B details a novel chemical resolution for NLG919 precursors, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN110564755B details a novel enzymatic route for (S)-3-phenyl-1,2-epoxypropane. Discover cost-effective, metal-free manufacturing solutions for high-purity API precursors.
Novel separation method for trans-1-2-cyclohexanediamine via patent CN117417259A. Enhances purity and supply chain efficiency for pharmaceutical intermediate manufacturing.
Advanced synthesis of loxoprofen metabolite avoids chromatography. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102643879B reveals microbial route for duloxetine intermediate. High purity, scalable production offers significant supply chain and cost advantages.
Novel Cu-catalyzed route for 3-sulfonylated-indanones. High yield, mild conditions. Cost-effective manufacturing for pharmaceutical intermediates.
Patent CN105541573A reveals a safer Wittig-Horner route for C20-dialdehyde. Discover cost reduction in carotenoid manufacturing and reliable supply chain solutions.
Novel isovaleraldehyde route enhances purity and yield. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel vanadium-catalyzed route offers high purity pregabalin. Reduces steps and improves yield for reliable API intermediate supplier.
Novel synthesis route for gamma-butyrolactone dimer anticancer compounds offers high purity and scalable manufacturing for pharmaceutical intermediates supply chains.
Patent CN102249882B details a safe, four-step synthesis for cyproconazole intermediates, eliminating active metals and toxic reagents for cost-effective manufacturing.
Patent CN102249882B details a safe, scalable route for Cyproconazole intermediates, eliminating hazardous metals and reducing manufacturing costs significantly.
Patent CN105111086A reveals high-yield Henry reaction route. Delivers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN106831862A introduces a novel chiral bridged ligand enhancing enantioselectivity in Suzuki reactions, offering cost-effective purification and reliable supply chain solutions for pharmaceutical intermediates.
Patent CN114539073A reveals a cost-effective route for 3-bromo-2-chloro-4,6-difluoroaniline. Discover scalable manufacturing and supply chain advantages for API intermediates.
Novel synthesis of Reidesciclovir intermediate via ammonium sulfate cyclization offers high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN102702123B reveals a one-pot synthesis for chiral fluorinated oxazolines. This method offers significant cost reduction and supply chain reliability for fine chemical manufacturing.